Showing 13 to 24 of 99 results
Stage Three Bowel Cancer Diagnosis Highlights Rise in Early-Onset Cases
Victoria Collins, a 40-year-old from Scotland, was diagnosed with stage three bowel cancer after experiencing symptoms initially mistaken for IBS; this highlights a concerning rise in early-onset bowel cancer cases among younger adults.
Stage Three Bowel Cancer Diagnosis Highlights Rise in Early-Onset Cases
Victoria Collins, a 40-year-old from Scotland, was diagnosed with stage three bowel cancer after experiencing symptoms initially mistaken for IBS; this highlights a concerning rise in early-onset bowel cancer cases among younger adults.
Progress
52% Bias Score
German Mammography Screening Reduces Breast Cancer Deaths
A German study reveals that the national mammography screening program, introduced 20 years ago, significantly reduces breast cancer mortality and improves survival rates among women aged 50-75, with a recommendation to lower the minimum age to 45 based on further findings.
German Mammography Screening Reduces Breast Cancer Deaths
A German study reveals that the national mammography screening program, introduced 20 years ago, significantly reduces breast cancer mortality and improves survival rates among women aged 50-75, with a recommendation to lower the minimum age to 45 based on further findings.
Progress
44% Bias Score
Los Angeles Wildfires: AI and Autonomous Technologies for Prevention and Mitigation
Devastating wildfires in Los Angeles in January 2025 resulted in 30 deaths, 200,000 evacuations, and over 18,000 destroyed structures, costing over \$100 billion to rebuild; analysis of social media reveals key recommendations for improved wildfire management strategies using AI and autonomous techn...
Los Angeles Wildfires: AI and Autonomous Technologies for Prevention and Mitigation
Devastating wildfires in Los Angeles in January 2025 resulted in 30 deaths, 200,000 evacuations, and over 18,000 destroyed structures, costing over \$100 billion to rebuild; analysis of social media reveals key recommendations for improved wildfire management strategies using AI and autonomous techn...
Progress
36% Bias Score
Rising Breast Cancer Rates in Young Women: A Call for Research
Rising breast cancer rates in young U.S. women (under 50) increased 1.4% annually (2012-2021), impacting all ethnic groups, particularly Asian Americans and Pacific Islanders (+50% since 2000), with several young celebrities' recent diagnoses raising awareness; aggressive cancers in younger women re...
Rising Breast Cancer Rates in Young Women: A Call for Research
Rising breast cancer rates in young U.S. women (under 50) increased 1.4% annually (2012-2021), impacting all ethnic groups, particularly Asian Americans and Pacific Islanders (+50% since 2000), with several young celebrities' recent diagnoses raising awareness; aggressive cancers in younger women re...
Progress
28% Bias Score
SiRNA Therapy Shows Promise in Preventing Huntington's Disease
Anastasia Khvorova's research at UMass Chan Medical School developed biochemically stabilized siRNA molecules capable of suppressing fatal Huntington's RNA for up to a year after a single dose, potentially preventing disease onset, thus shifting the focus from treatment to prevention of Huntington's...
SiRNA Therapy Shows Promise in Preventing Huntington's Disease
Anastasia Khvorova's research at UMass Chan Medical School developed biochemically stabilized siRNA molecules capable of suppressing fatal Huntington's RNA for up to a year after a single dose, potentially preventing disease onset, thus shifting the focus from treatment to prevention of Huntington's...
Progress
40% Bias Score
PromarkerEso Blood Test Shows High Accuracy in Detecting Oesophageal Cancer
Proteomics International Laboratories' PromarkerEso blood test for oesophageal cancer showed 91.4% accuracy in detecting the cancer and 98.9% accuracy in identifying those without it in a 259-person study, exceeding the accuracy of existing tests and paving the way for commercial release.
PromarkerEso Blood Test Shows High Accuracy in Detecting Oesophageal Cancer
Proteomics International Laboratories' PromarkerEso blood test for oesophageal cancer showed 91.4% accuracy in detecting the cancer and 98.9% accuracy in identifying those without it in a 259-person study, exceeding the accuracy of existing tests and paving the way for commercial release.
Progress
56% Bias Score
Dogs Detect Parkinson's Disease Years Before Symptoms Appear
A new study shows dogs can detect Parkinson's disease through skin odor with 98% accuracy, years before symptoms appear, potentially revolutionizing early diagnosis and treatment using trained dogs to identify a unique scent signature.
Dogs Detect Parkinson's Disease Years Before Symptoms Appear
A new study shows dogs can detect Parkinson's disease through skin odor with 98% accuracy, years before symptoms appear, potentially revolutionizing early diagnosis and treatment using trained dogs to identify a unique scent signature.
Progress
48% Bias Score
German Breast Cancer: Treatment Advancements Drive High Survival Rates
In Germany, approximately 1 in 8 women develop breast cancer, a figure attributed to lifestyle, diet, and environmental factors; however, advancements in treatments like targeted antibodies and immunotherapies have led to 80–90% survival rates across all stages.
German Breast Cancer: Treatment Advancements Drive High Survival Rates
In Germany, approximately 1 in 8 women develop breast cancer, a figure attributed to lifestyle, diet, and environmental factors; however, advancements in treatments like targeted antibodies and immunotherapies have led to 80–90% survival rates across all stages.
Progress
44% Bias Score
NSW Deputy Premier Prue Car Takes Leave After Breast Cancer Diagnosis
NSW Deputy Premier and Education Minister Prue Car, 43, will take indefinite leave after an early diagnosis of breast cancer; this is unrelated to her 2022 kidney cancer diagnosis; Courtney Houssos will act in her ministerial roles.
NSW Deputy Premier Prue Car Takes Leave After Breast Cancer Diagnosis
NSW Deputy Premier and Education Minister Prue Car, 43, will take indefinite leave after an early diagnosis of breast cancer; this is unrelated to her 2022 kidney cancer diagnosis; Courtney Houssos will act in her ministerial roles.
Progress
20% Bias Score
Highly Accurate Blood Test Detects Early-Stage Alzheimer's
A new blood test for Alzheimer's, using amyloid beta 42/40 and p-tau217 proteins, achieves 95% sensitivity and 82% specificity in detecting early symptoms, surpassing invasive tests in convenience and cost-effectiveness, and is FDA-approved.
Highly Accurate Blood Test Detects Early-Stage Alzheimer's
A new blood test for Alzheimer's, using amyloid beta 42/40 and p-tau217 proteins, achieves 95% sensitivity and 82% specificity in detecting early symptoms, surpassing invasive tests in convenience and cost-effectiveness, and is FDA-approved.
Progress
36% Bias Score
AI: Revolutionizing Cancer Care Affordability and Outcomes
AI is revolutionizing cancer care, lowering costs and improving survival. Early detection tools, like those used at The Christ Hospital, increase early diagnoses. Personalized treatments, such as ArteraAI's Prostate Test, reduce unnecessary therapies. AI-powered surgery and infection monitoring (Tem...
AI: Revolutionizing Cancer Care Affordability and Outcomes
AI is revolutionizing cancer care, lowering costs and improving survival. Early detection tools, like those used at The Christ Hospital, increase early diagnoses. Personalized treatments, such as ArteraAI's Prostate Test, reduce unnecessary therapies. AI-powered surgery and infection monitoring (Tem...
Progress
40% Bias Score
Liquid Biopsy Shows Promise for Early Detection and Prevention of Breast Cancer Relapse
A new blood test, "liquid biopsy," detects breast cancer relapse earlier than traditional methods, allowing for preventive treatment with camizestrant, showing a 56% reduction in disease progression risk in a clinical trial involving 3000 patients.
Liquid Biopsy Shows Promise for Early Detection and Prevention of Breast Cancer Relapse
A new blood test, "liquid biopsy," detects breast cancer relapse earlier than traditional methods, allowing for preventive treatment with camizestrant, showing a 56% reduction in disease progression risk in a clinical trial involving 3000 patients.
Progress
48% Bias Score
Showing 13 to 24 of 99 results